EUROMEDICAHanover23-24 Mai 2011 |
Advanced methods of diagnosis,
|
European Academy of Natural Sciences, HanoverEuropean Scientific Society, Hanover |
Home |
Abstracts |
Contact |
|
|
|
Disclaimer |
| T.E. Belousova | ANTIHOMOTOXIC SUPERVISION OF PATIENTS WITH CHRONIC DISEASES IN FAMILY DOCTOR’S PRACTICE |
| Nizhny Novgorod State Medical Academy, Nizhny Novgorod, Russia |
Generally a family doctor carries out a large scope of medical and health-improving activities because the final goal of their work is a high quality level of a patient under supervision. Most often the peculiarity of the family doctors’ patient pathology is a sluggish character of chronic internal diseases with exacerbations of moderate expressivity. The most widely spread patient’s problems are diseases of respiratory, cardiovascular and cerebrovascular systems, arthropathy, vertebral diseases, diverse clinical presentations of metabolic syndrome. Considerable negative environmental and social changes occurring within the recent 15-20 years cause the need in supplementing therapeutic standards with modern naturopathic technologies.
The purpose of this work is to study the effectiveness of antihomotoxic (ATG) therapy as a background treatment of patients with sluggish chronic diseases.
Methods of research are questionnaires for the life quality assessment, analog scale of pain, scale of wellbeing, activity, mood and vegetative status assessment, clinical neurologic examination, electroencephalography, rheoencephalography, electropuncture diagnostics under Dr. Voll’s method.
435 patients from 142 families were under our observation for different chronic diseases within 5-7 years. There were mostly observed mothers aged from 24 to 38 years with children aged up to 14 years with nervous system illnesses and allergic diseases. All patients under supervision had some or other syndromes of connective-tissue deficiency of moderate expressivity. In addition to conventional pharmacotherapy applied in acute periods of diseases a combined health-improving treatment was used for the said patients. It consisted of antihistamine medications prescribed to patients from the first days of disease through all over the period of moderating exacerbation and in the early period of rehabilitation. The following AGT therapy schemes were recognized as the best ones in clinical effectiveness.
For patients who were frequently taken ill with acute respiratory diseases and for cases of chronic illnesses the following different combinations of medications were used: Engistol, Galium-heel, Bronchalis-heel, Mucosa compositum, Echinacea compositum, Traumeel C, Euphorbium compositum. After 2-3 therapy courses within a year or a year and a half the clinical effectiveness was 77.3% (47.8% in a controlled group).
In case of allergosis Galium-heel, Lymphomiosot, Psorinoheel, Cutis compositum, Mucosa compositum, Luffel were used. After 2-3 therapy courses within one or two years the clinical effectiveness is 77.3% (39.6% in a controlled group). For aftereffects of perinatal encephalopathy, infantile cerebral paralysis, IFBBSD - Cerebrum compositum, Traumeel C, Coenzyme compositum, Ubichinon compositum, Placenta compositum, Hepar compositum, Momordica, Vertigoheel, Nervoheel, Valerianaheel were applied. After 3-4 therapy courses within one year and a half or three years the clinical effectiveness was 78.9% (54.5% in a controlled group).
In case of faults in posture, arthropathy and vertebral diseases Traumeel S, Cell T, Discus compositum, Placenta compositum were used. After 2-3 therapy courses within a year or a year and a half the clinical effectiveness was 79.2% (53.7% in a controlled group).
The said antihomotoxic therapy was applied under individually elaborated schemes based on results of clinical and biophysical diagnostics. Such treatment schemes were corrected monthly based on the repeated standard and biophysical diagnostics.
Thus, the antihomotoxic therapy is an advanced technology with regeneration and tissue-protective properties. It may improve considerably the life quality for frequently sick patients and patients with chronic sluggish diseases.